Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Multiple cytokine-producing testicular malignant lymphoma with clinical symptoms resembling infectious signs.

Nakayama S, Yokote T, Tsuji M, Hirata Y, Iwaki K, Takayama A, Nishiwaki U, Hiraoka N, Akioka T, Miyoshi T, Masuda Y, Hanafusa T.

Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):103-7.

PMID:
24674684
2.

Expression of multiple cytokines and CCR4 in primary testicular diffuse large B-cell lymphoma, not otherwise specified, involving the skin.

Nakayama-Ichiyama S, Iwaki K, Yokote T, Tsuji M, Hirata Y, Hanafusa T.

Br J Haematol. 2012 Feb;156(4):420. doi: 10.1111/j.1365-2141.2011.08943.x. No abstract available.

PMID:
22098482
3.

TNF-α expression in tumor cells as a novel prognostic marker for diffuse large B-cell lymphoma, not otherwise specified.

Nakayama S, Yokote T, Hirata Y, Akioka T, Miyoshi T, Hiraoka N, Iwaki K, Takayama A, Nishiwaki U, Masuda Y, Nishimura Y, Tsuji M, Hanafusa T.

Am J Surg Pathol. 2014 Feb;38(2):228-34. doi: 10.1097/PAS.0000000000000094.

PMID:
24145654
4.

Multiple cytokine- and chemokine-producing primary testicular diffuse large B-cell lymphoma, not otherwise specified.

Nakayama S, Yokote T, Iwaki K, Hirata Y, Nishiwaki U, Akioka T, Miyoshi T, Masuda Y, Tsuji M, Hanafusa T.

Leuk Res. 2012 Aug;36(8):e171-4. doi: 10.1016/j.leukres.2012.04.032. No abstract available.

PMID:
22652076
7.

Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction.

Melhem MF, Meisler AI, Saito R, Finley GG, Hockman HR, Koski RA.

Blood. 1993 Oct 1;82(7):2038-44.

8.

Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis.

Ferry JA, Harris NL, Young RH, Coen J, Zietman A, Scully RE.

Am J Surg Pathol. 1994 Apr;18(4):376-90.

PMID:
8141430
9.

Microscopic diffuse large B-cell lymphoma (DLBCL) occurring in pseudocysts: do these tumors belong to the category of DLBCL associated with chronic inflammation?

Boroumand N, Ly TL, Sonstein J, Medeiros LJ.

Am J Surg Pathol. 2012 Jul;36(7):1074-80. doi: 10.1097/PAS.0b013e3182515fb5. Review.

PMID:
22472958
10.

Co-expression of multiple cytokines and their receptors in primary clear cell sarcoma of the pubic bone with features of a small round cell tumor.

Nakayama S, Yokote T, Iwaki K, Hirata Y, Akioka T, Miyoshi T, Takayama A, Nishiwaki U, Masuda Y, Tsuji M, Hanafusa T.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):799-804.

PMID:
23058034
11.

Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma with the expression of other cytokines.

Yoshimoto A, Kasahara K, Saito K, Fujimura M, Nakao S.

Int J Clin Oncol. 2005 Feb;10(1):58-62.

PMID:
15729603
12.

[Testicular lymphoma: report of 4 cases].

Chelly I, Mekni A, Bellil K, Belhadj Salah M, Bellil S, Haouet S, Kchir N, Horchani A, Zitouna MM.

Tunis Med. 2007 Oct;85(10):896-8. French.

PMID:
18236816
13.

Autocrine growth promotion by multiple hematopoietic growth factors in the established renal cell carcinoma line KU-19-20.

Tachibana M, Miyakawa A, Nakashima J, Murai M, Nakamura K, Kubo A, Hata J.

Cell Tissue Res. 2000 Sep;301(3):353-67.

PMID:
10994781
14.

[Limbic encephalitis in the course of testicular lymphoma].

Oshinomi K, Shimada M, Inoue K, Shiiki K, Sugawara S, Nagata M, Maeda T, Ogawa Y.

Nihon Hinyokika Gakkai Zasshi. 2010 Jan;101(1):34-7. Japanese.

PMID:
20158077
15.

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.

Lech-Maranda E, Bienvenu J, Broussais-Guillaumot F, Warzocha K, Michallet AS, Robak T, Coiffier B, Salles G.

Arch Immunol Ther Exp (Warsz). 2010 Apr;58(2):131-41. doi: 10.1007/s00005-010-0066-1.

PMID:
20191326
16.

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.

Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.

J Surg Oncol. 2003 Nov;84(3):151-9.

PMID:
14598359
17.

Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.

Cocco C, Di Carlo E, Zupo S, Canale S, Zorzoli A, Ribatti D, Morandi F, Ognio E, Airoldi I.

Leukemia. 2012 Jun;26(6):1365-74. doi: 10.1038/leu.2011.363.

PMID:
22193967
18.

Anaplastic large cell lymphoma with paraneoplastic leukocytosis: a clinicopathological analysis of five cases.

Chang IW, Chen HK, Ma MC, Huang WT.

APMIS. 2011 Nov;119(11):794-801. doi: 10.1111/j.1600-0463.2011.02811.x.

PMID:
21995633
19.

Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.

Charbonneau B, Maurer MJ, Ansell SM, Slager SL, Fredericksen ZS, Ziesmer SC, Macon WR, Habermann TM, Witzig TE, Link BK, Cerhan JR, Novak AJ.

Cytokine. 2012 Dec;60(3):882-9. doi: 10.1016/j.cyto.2012.08.028.

20.

A case of squamous cell carcinoma of the head and neck producing granulocyte-colony stimulating factor with marked leukocytosis.

Toyoda M, Chikamatsu K, Sakakura K, Fukuda Y, Takahashi K, Miyashita M, Shimamura K, Furuya N.

Auris Nasus Larynx. 2007 Jun;34(2):267-71.

PMID:
17097253
Items per page

Supplemental Content

Support Center